Zacks: Nuvectra Corp. (NVTR) Given $11.00 Average Target Price by Brokerages
Nuvectra Corp. (NASDAQ:NVTR) has received a consensus broker rating score of 2.00 (Buy) from the two analysts that provide coverage for the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold recommendation and one has given a strong buy recommendation to the company.
Brokerages have set a one year consensus price target of $11.00 for the company and are predicting that the company will post ($0.88) earnings per share for the current quarter, according to Zacks. Zacks has also given Nuvectra Corp. an industry rank of 111 out of 265 based on the ratings given to related companies.
NVTR has been the subject of several research reports. B. Riley initiated coverage on shares of Nuvectra Corp. in a research report on Wednesday, September 21st. They set a “buy” rating and a $12.00 price objective for the company. Piper Jaffray Cos. reissued a “neutral” rating and set a $10.00 price objective (down previously from $12.00) on shares of Nuvectra Corp. in a research report on Saturday, August 13th.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/14/zacks-nuvectra-corp-nvtr-given-11-00-average-target-price-by-brokerages.html
Shares of Nuvectra Corp. (NASDAQ:NVTR) traded down 0.31% on Friday, reaching $6.42. 9,251 shares of the company traded hands. Nuvectra Corp. has a 52-week low of $4.02 and a 52-week high of $11.64. The stock has a 50 day moving average of $6.74 and a 200 day moving average of $7.29. The stock’s market cap is $65.98 million.
Nuvectra Corp. (NASDAQ:NVTR) last issued its quarterly earnings data on Wednesday, August 10th. The company reported ($0.85) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($1.13) by $0.28. The company had revenue of $2.50 million for the quarter, compared to the consensus estimate of $2.40 million. Nuvectra Corp.’s revenue for the quarter was up 66.7% compared to the same quarter last year. On average, analysts expect that Nuvectra Corp. will post ($3.37) earnings per share for the current year.
Nuvectra Corp. Company Profile
Nuvectra Corporation, formerly QIG Group, LLC, is a neurostimulation company. The Company is focused on the development and commercialization of a neurostimulation technology platform, which is used for the treatment of various disorders through stimulation of tissues associated with the nervous system.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nuvectra Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvectra Corp. and related companies with MarketBeat.com's FREE daily email newsletter.